annual cash & cash equivalents:
$779.71M+$185.71M(+31.26%)Summary
- As of today (May 20, 2025), PTCT annual cash & cash equivalents is $779.71 million, with the most recent change of +$185.71 million (+31.26%) on December 31, 2024.
- During the last 3 years, PTCT annual cash & cash equivalents has risen by +$589.99 million (+310.98%).
- PTCT annual cash & cash equivalents is now at all-time high.
Performance
PTCT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.48B+$700.52M(+89.84%)Summary
- As of today (May 20, 2025), PTCT quarterly cash & cash equivalents is $1.48 billion, with the most recent change of +$700.52 million (+89.84%) on March 1, 2025.
- Over the past year, PTCT quarterly cash & cash equivalents has increased by +$931.88 million (+169.94%).
- PTCT quarterly cash & cash equivalents is now at all-time high.
Performance
PTCT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PTCT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.3% | +169.9% |
| 3 y3 years | +311.0% | +926.7% |
| 5 y5 years | +170.7% | +1100.6% |
PTCT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +311.0% | at high | +1317.5% |
| 5 y | 5-year | at high | +311.0% | at high | +1317.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
PTCT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.48B(+89.8%) |
| Dec 2024 | $779.71M(+31.3%) | $779.71M(+48.2%) |
| Sep 2024 | - | $526.00M(-19.7%) |
| Jun 2024 | - | $654.78M(+19.4%) |
| Mar 2024 | - | $548.36M(-7.7%) |
| Dec 2023 | $594.00M(+112.3%) | $594.00M(+259.7%) |
| Sep 2023 | - | $165.16M(-20.7%) |
| Jun 2023 | - | $208.39M(+24.4%) |
| Mar 2023 | - | $167.50M(-40.1%) |
| Dec 2022 | $279.83M(+47.5%) | $279.83M(+168.0%) |
| Sep 2022 | - | $104.42M(-34.0%) |
| Jun 2022 | - | $158.16M(+9.7%) |
| Mar 2022 | - | $144.18M(-24.0%) |
| Dec 2021 | $189.72M(-9.1%) | $189.72M(-0.1%) |
| Sep 2021 | - | $189.82M(+7.0%) |
| Jun 2021 | - | $177.35M(+20.9%) |
| Mar 2021 | - | $146.63M(-29.8%) |
| Dec 2020 | $208.81M(-27.5%) | $208.81M(-51.9%) |
| Sep 2020 | - | $433.97M(+173.9%) |
| Jun 2020 | - | $158.46M(+28.5%) |
| Mar 2020 | - | $123.29M(-57.2%) |
| Dec 2019 | $288.03M(+69.9%) | $288.03M(-45.0%) |
| Sep 2019 | - | $523.58M(+284.7%) |
| Jun 2019 | - | $136.09M(-32.3%) |
| Mar 2019 | - | $201.14M(+18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $169.50M(+51.6%) | $169.50M(-18.1%) |
| Sep 2018 | - | $206.91M(-7.5%) |
| Jun 2018 | - | $223.79M(+129.1%) |
| Mar 2018 | - | $97.67M(-12.6%) |
| Dec 2017 | $111.79M(+91.7%) | $111.79M(-21.2%) |
| Sep 2017 | - | $141.84M(+6.6%) |
| Jun 2017 | - | $133.01M(+145.8%) |
| Mar 2017 | - | $54.11M(-7.2%) |
| Dec 2016 | $58.32M(+0.5%) | $58.32M(+16.0%) |
| Sep 2016 | - | $50.29M(+41.0%) |
| Jun 2016 | - | $35.66M(-11.2%) |
| Mar 2016 | - | $40.16M(-30.8%) |
| Dec 2015 | $58.02M(+16.6%) | $58.02M(-58.8%) |
| Sep 2015 | - | $140.71M(+381.6%) |
| Jun 2015 | - | $29.22M(-20.7%) |
| Mar 2015 | - | $36.83M(-26.0%) |
| Dec 2014 | $49.75M(+222.7%) | $49.75M(-5.9%) |
| Sep 2014 | - | $52.87M(+149.7%) |
| Jun 2014 | - | $21.17M(-81.7%) |
| Mar 2014 | - | $115.86M(+651.6%) |
| Dec 2013 | $15.41M(+465.5%) | $15.41M(-35.9%) |
| Sep 2013 | - | $24.04M(-84.4%) |
| Jun 2013 | - | $154.10M(+181.5%) |
| Mar 2013 | - | $54.75M(+1908.5%) |
| Dec 2012 | $2.73M(-90.4%) | $2.73M |
| Dec 2011 | $28.43M | - |
FAQ
- What is PTC Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PTC Therapeutics?
- What is PTC Therapeutics annual cash & cash equivalents year-on-year change?
- What is PTC Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for PTC Therapeutics?
- What is PTC Therapeutics quarterly cash & cash equivalents year-on-year change?
What is PTC Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PTCT is $779.71M
What is the all time high annual cash & cash equivalents for PTC Therapeutics?
PTC Therapeutics all-time high annual cash & cash equivalents is $779.71M
What is PTC Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, PTCT annual cash & cash equivalents has changed by +$185.71M (+31.26%)
What is PTC Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PTCT is $1.48B
What is the all time high quarterly cash & cash equivalents for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash & cash equivalents is $1.48B
What is PTC Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, PTCT quarterly cash & cash equivalents has changed by +$931.88M (+169.94%)